AdvanDx Secures $2,500,000 New Funding Round
- Feed Type
- Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=36211dbf-c5be-4eb0-a1a1-0eb6ce9064e6 - Date
3/18/2015 - Company Name
AdvanDx - Mailing Address
400 TradeCenter Woburn, MA 01801 USA - Company Description
AdvanDx develops and markets molecular-based, in vitro diagnostic tests that aid in the diagnosis and prevention of infectious diseases. The rapid test results are available in hours instead of days and allow healthcare providers to make more informed therapy decisions early and improve both the quality of patient care and overall hospital operations. - Website
http://www.advandx.com - Transaction Type
Debt - Transaction Amount
$2,500,000 - Transaction Round
Undisclosed - Proceeds Purposes
Proceeds purposes were not disclosed. SEC regulatory filing. Contact technology company for investment details, if applicable. Not an offer or solicitation for sale of securities. - M&A Terms
- Venture Investor
